Comparison of results of a pilot study of alternating vincristine/doxorubicin/cyclophosphamide and etoposide/ifosfamide with IRS-IV in intermediate risk rhabdomyosarcoma: A report from the Children's Oncology Group-Reference-Cited by-同舟云学术

Comparison of results of a pilot study of alternating vincristine/doxorubicin/cyclophosphamide and etoposide/ifosfamide with IRS-IV in intermediate risk rhabdomyosarcoma: A report from the Children's Oncology Group

Published:2008-01 Issue:1 Volume:50 Page:33-36
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr. Blood Cancer

Author:

Arndt Carola A.S.,Hawkins Douglas S.,Meyer William H.,Sencer Susan F.,Neglia Joseph P.,Anderson James R.

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Reference23 articles.

1. Soft tissue sarcomas of childhood

2. Rhabdomyosarcoma and Undifferentiated Sarcoma in the First Two Decades of Life: A Selective Review of Intergroup Rhabdomyosarcoma Study Group Experience and Rationale for Intergroup Rhabdomyosarcoma Study V

3. The intergroup rhabdomyosarcoma study-I.A final report

4. The intergroup rhabdomyosarcoma study-II

5. The Third Intergroup Rhabdomyosarcoma Study.

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical characteristics and outcomes of adult alveolar rhabdomyosarcoma patients on first-line systemic therapies: A single-institution cohort;Rare Tumors;2024-02

2. Next generation sequencing predicting clinical effect of immunotherapy on adult rhabdomyosarcoma patient: A case report;Medicine;2023-05-26

3. Oral vinorelbine and continuous low doses of cyclophosphamide in pediatric rhabdomyosarcoma: a real-world study;Frontiers in Pharmacology;2023-05-03

4. Feasibility and Toxicity of Interval-Compressed Chemotherapy in Asian Children and Young Adults with Sarcoma;Journal of Personalized Medicine;2023-04-14

5. Treatment of spinal rhabdomyosarcoma in adults: A case report and literature review of current evidence;Oncology Letters;2023-01-30